8OUS image
Entry Detail
PDB ID:
8OUS
Keywords:
SIGNALING PROTEIN
Title:
CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 19
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Trichoplusia ni
PDB Version:
Deposition Date:
2023-04-24
Release Date:
2023-07-26
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.20 Å
R-Value Free:
0.25
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 1 21 1
8OUS validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Mitogen-activated protein kinase kinase kinase 12
Chain IDs:A
Chain Length:300
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:Q12852 Pfam ID:PF07714
Ligand Molecules
W3I
Primary Citation
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy.
J.Med.Chem. 66 9954 9971 (2023)
PMID: 37436942 DOI: 10.1021/acs.jmedchem.3c00788

Abstact

Chemotherapy-induced peripheral neuropathy (CIPN) is a major unmet medical need with limited treatment options. Despite different mechanisms of action, diverse chemotherapeutics can cause CIPN through a converged pathway─an active axon degeneration program that engages the dual leucine zipper kinase (DLK). DLK is a neuronally enriched kinase upstream in the MAPK-JNK cascade, and while it is dormant under physiological conditions, DLK mediates a core mechanism for neuronal injury response under stress conditions, making it an attractive target for treatment of neuronal injury and neurodegenerative diseases. We have developed potent, selective, brain penetrant DLK inhibitors with excellent PK and activity in mouse models of CIPN. Lead compound IACS-52825 (22) showed strongly effective reversal of mechanical allodynia in a mouse model of CIPN and was advanced into preclinical development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
8OUS